BCL3 Antikörper (Middle Region)
-
- Target Alle BCL3 Antikörper anzeigen
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
-
Bindungsspezifität
- AA 248-277, Middle Region
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BCL3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody reacts to Bcl-3.
- Kreuzreaktivität (Details)
- Species reactivity (tested):Human and Mouse.
- Aufreinigung
- Affinity chromatography on Protein A
- Immunogen
- KLH conjugated synthetic peptide between 248~277 amino acids from the Center region of human BCL3
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product BCL3 Primärantikörper
-
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 300-400) antibody
BCL3 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 362-454) antibodyBCL3 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 249-277), (Center) antibodyBCL3 Reaktivität: Human, Maus WB, FACS, IF, IHC (p) Wirt: Kaninchen Polyclonal RB23954 unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (C-Term) antibodyBCL3 Reaktivität: Human WB, ELISA, IHC, IP, FACS, FM Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 82-341) antibodyBCL3 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) antibodyBCL3 Reaktivität: Human WB, ICC, DB Wirt: Maus Monoclonal 2069E2a unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 1-446) antibodyBCL3 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 1-446) antibodyBCL3 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 2-13) antibodyBCL3 Reaktivität: Human WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 127-376) antibodyBCL3 Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS containing 0.09 % (W/V) sodium azide as preservative
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
- Andere Bezeichnung
- Bcl-3 (BCL3 Produkte)
- Synonyme
- BCL3 antikoerper, AI528691 antikoerper, Bcl-3 antikoerper, BCL4 antikoerper, D19S37 antikoerper, B-cell CLL/lymphoma 3 antikoerper, B cell leukemia/lymphoma 3 antikoerper, BCL3 antikoerper, Bcl3 antikoerper
- Hintergrund
- BCL3 is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers.Synonyms: B-cell lymphoma 3-encoded protein, BCL3, BCL4, D19S37
- Gen-ID
- 602
- NCBI Accession
- NP_005169
- Pathways
- NF-kappaB Signalweg, Maintenance of Protein Location, Protein targeting to Nucleus
-
